PMK 006 Total Heart Health
Natural health product licensed in Canada
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Esters de stérol végétal Source : Triticum aestivum (whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 400 milligramme | Not calculated |
| Esters de stérol végétal Source : Glycine max - Graine Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 400 milligramme | Not calculated |
| Esters de stérol végétal Source : Arachis hypogaea (Whole) Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 400 milligramme | Not calculated |
| Esters de stérol végétal Source : Brassica napus - entier Potency : 80 % Combined beta-Sitosterol, Campesterol and Stigmasterol | 400 milligramme | Not calculated |
Non-medicinal ingredients
Gélatine, Glycérine, Eau purifiée, Huile de fève de soja
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2 Capsule | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine to help reduce elevated blood lipid levels in adults. Used in Herbal Medicine to help reduce hyperlipidaemia in adults. Helps maintain healthy cholesterol levels and lower blood total LDL cholesterol. Used in Herbal Medicine to help maintain cardiovascular health in adults. Used in Herbal Medicine to help support cardiovascular health in adults. Hawthorn is traditionally used in Herbal Medicine to help maintain and support cardiovascular health in adults.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Hypersensitivity (e.g. allergy) has been known to occur; in which case discontinue use.
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you are taking blood pressure medication, blood thinners, protease inhibitors or cardiac glycosides such as digitalis/digoxin.
Product record
- Other names
- Total Heart Health
- Licence holder
- PMK Federal Regulatory Consultants Ltd.
- NPN or DIN-HM
- 80032859
- Status
- Active licence
- Licence date
- 15 June 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
Source
Official Health Canada record, licence 80032859
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “PMK 006 Total Heart Health (PMK Federal Regulatory Consultants Ltd.): composition and ingredients”, https://compoatlas.com/en/supplements/canada/80032859-pmk-006-total-heart-health, updated 15 June 2012.